Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Ming-Jang Chiu
CONTACT
Lead
National Taiwan University Hospital
With
This is a double-blind, randomized, placebo-controlled, dose-escalating study. The study comprises single dose (Stage I) and multiple dose (Stage II) stages. Stage II will not be initiated until completion of Stage I. The interim safety analysis report will be submitted to TFDA for an approval for proceeding to Stage II.
Age
20–45
Sex
MALE
Healthy volunteers
Accepted